Search for: [Abstract = "pic guidance. Vascular accesses wereclosed with Angio\-Seal vascular closure device \(St. Jude Medical,USA\) or with manual compression. Baseline and procedural characteristics, as well as long\-term outcomes were assessed in three groups \- stand alone BAV, BAV with coronary angiography \(only\),and BAV combined with PCI. In case of TAVI after valve deployment angiography, echocardiography, and the aortic regurgitation index\(ARI\) were used to assess the severity of PVL before and after balloonPD. Patients were divided into two groups based whether or not PDafter TAVI was performed. Reduction of PVL, change of ARI, andclinical outcomes was assessed. \; Results In the first analysis, a total of 114 BAVs were performed in 112 patients. The leading indication for BAV was bridge for TAVI \(n=58,51.8%\). Others included bridge for AVR \(n=6, 5.4%\), palliative treatment \(n=37, 33.0%\), cardiogenic shock \(n=2, 1.8%\), and urgent non\-cardiac surgery \(n=9, 8.0%\). To sum up, during follow\-up, 23\(20.5%\) of patients after BAV underwent TAVI and 11 \(9.8%\)patients underwent AVR. A total of 89.3% of patients were in NYHAclass III or IV. Median of STS score was 8.0 \(5.5\-10.6\)% andEuroscore II 8.1 \(5.1\-11.8\)%. Vascular closure device was used in 37\(33%\) patients. Echocardiograms performed after BAV and at 1, 6, 12months showed that AVA was higher \(\+0.23, \+0.15, \+0.05, \+0.05cm2, respectively, p<0.05 for all\)"]

Number of results: 1